Application 202543
- Type
- NDA
- Sponsor
- HQ SPECIALITY PHARMA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 500MG/100ML (5MG/ML) | Yes | Yes |
| 002 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1000MG/100ML (10MG/ML) | Yes | Yes |
| 003 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 1500MG/100ML (15MG/ML) | Yes | Yes |
| 004 | LEVETIRACETAM IN SODIUM CHLORIDE | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 250MG/50ML (5MG/ML) | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 44567-500 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-500 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-500 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-501 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-501 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-501 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-501 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-502 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-502 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-502 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-502 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-503 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-503 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 44567-503 | Levetiracetam | Levetiracetam | WG Critical Care, LLC | NDA | Current |
| 67457-255 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-255 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-255 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-255 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-255 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-265 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-265 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-265 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-265 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-265 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-266 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-266 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-266 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-266 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |
| 67457-266 | Levetiracetam | Levetiracetam | Mylan Institutional LLC | NDA | Current |